BioHealth News Archive
Biohealth Innovation – SBIR Virtual Office Hours (BHI and MCEDC) (June 9)
Are you and early stage company with innovative biohealth technology? Have you considered non-dilutive funding to advance your technology? Learn more about whether or…
Read MoreBiohealth Innovation – SBIR Virtual Office Hours (BHI and MCEDC) (June 9)
Are you and early stage company with innovative biohealth technology? Have you considered non-dilutive funding to advance your technology? Learn more about whether or…
Read MoreRoosterBio Releases RoosterGEM™, Cell and Gene Therapy’s First Complete Transduction Medium
RoosterBio Inc., a leading supplier of human mesenchymal stem/stromal cell (hMSC) working cell banks and hMSC bioprocess systems for cell and gene therapy product…
Read MoreBHI NIH Entrepreneur-In-Residence Job Opening
BioHealth Innovation, Inc. (BHI), is a Montgomery County innovation intermediary which translates market-relevant research into commercial success by bringing together management, funding, and markets.…
Read MoreBHI NIH Entrepreneur-In-Residence Job Opening
BioHealth Innovation, Inc. (BHI), is a Montgomery County innovation intermediary which translates market-relevant research into commercial success by bringing together management, funding, and markets.…
Read MoreBHI EIR Feedback Day May 26th. – Register Now!
Are you a biohealth start-up in Maryland, DC or Virginia seeking feedback on your biohealth business idea, pitch deck, or commercialization plan? Schedule your…
Read MoreBHI EIR Feedback Day May 26th. – Register Now!
Are you a biohealth start-up in Maryland, DC or Virginia seeking feedback on your biohealth business idea, pitch deck, or commercialization plan? Schedule your…
Read MoreBlu Ventures Launches $25M Venture Capital Fund Focused on Cybersecurity
Blu Venture Investors, a Vienna, VA-based venture capital firm supporting the cybersecurity ecosystem in the Mid-Atlantic region and beyond, launched a $25M fund. The BVI Cyber…
Read MoreRockville’s Integrated BioTherapeutics Inc. Awarded $16.3M Contract from the National Institute of Allergy and Infectious Diseases to Develop a Treatment for Marburg Virus Disease · BioBuzz
Integrated BioTherapeutics Inc. (IBT), a Maryland biotechnology company specializing in emerging infectious diseases, announced today the receipt of a contract valued at up to…
Read MoreConnected DMV Announces DMV Regional Congress to Promote Economic Renewal, Social Equity
May 20, 2021 (Washington, D.C.)- Connected DMV held its ninth and final COVID-19 Strategic Renewal Task Force meeting, where they announced the formation of…
Read MoreQiagen N.V. – QIAGEN Receives U.S. FDA Emergency Use Authorization for Fast and Easy-to-Use Digital Test to Detect SARS-CoV-2 Coronavirus Antibodies
GERMANTOWN, Md. & HILDEN, Germany--(BUSINESS WIRE)-- QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced it has received Emergency Use Authorization (EUA) from…
Read MoreMaryland Tech Council Announces 2021 Industry Awards Celebration Winners | Business Wire
FREDERICK, Md.--(BUSINESS WIRE)--Today, the Maryland Tech Council (MTC), Maryland’s largest technology and life sciences trade association, announced the winners for its annual Industry Awards…
Read MoreA network analysis of COVID-19 mRNA vaccine patents | Nature Biotechnology
The COVID-19 pandemic has had a substantial impact on global health and highlighted the importance of international cooperation to effectively combat SARS-CoV-2. Since the…
Read MoreSemiconductor shortages dragged down April employment, other takeaways from a dive into the jobs data | SSTI
The April jobs report, released by the Bureau of Labor Statistics on May 7, generated considerable attention due to the 266,000 jobs added being…
Read MoreSponsored Content: New COVID-19 AI app replaces uncertainty with needed clarity and a sense of control – POLITICO
The universal impact of the COVID-19 pandemic has forever changed our understanding of the lives we knew both collectively and personally. No one is…
Read More